Corpay saw its IBD SmartSelect Composite Rating rise to 97 Monday, up from 93 the day before.
The new score tells you the company is now outperforming 97% of all stocks in terms of the most important fundamental and technical stock-picking criteria. The top-performing stocks tend to have a 95 or better grade as they start a significant move so be sure to keep that in mind when looking for the best stocks to buy and watch.
Corpay is now out of buy range after breaking out from a 302.01 entry in a cup with handle.
Lean How — And When — To Sell Stocks
The stock sports an 87 EPS Rating, which means its recent quarterly and annual earnings growth is outpacing 87% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
In Q3, the company reported 11% earnings-per-share growth. That marks two straight quarters of rising EPS performance. Revenue growth increased 6%, up from 3% in the prior quarter. That marks one quarter of rising revenue growth.
Corpay holds the No. 4 rank among its peers in the Financial Services-Specialty industry group. Marex Group is the top-ranked stock within the group.
